Pharmacotherapy for obsessive-compulsive
β
Darin D. Dougherty; Scott L. Rauch; Michael A. Jenike
π
Article
π
2004
π
John Wiley and Sons
π
English
β 69 KB
## Abstract Pharmacotherapeutic options for obsessiveβcompulsive disorder (OCD) have expanded over the past halfβcentury since medications were first found to be effective for the treatment of OCD. Currently, the serotonin reuptake inhibitors (SRIs) represent the firstβline pharmacotherapy for OCD.